Judy F. Gordon, DVM, Founder of ClinReg Consulting Services, Retires
Medical device and pharmaceutical consulting company ClinReg Consulting Services announced the retirement of its founder and president, Judy F. Gordon, DVM.
Dr. Gordon has worked in the clinical and regulatory industry for more than 35 years, beginning with her career in the pharmaceutical industry in 1983 at Newport Pharmaceuticals. She went on to work for Chiron Vision, solidifying her focus on ophthalmic products and devices. In 1998, Dr. Gordon founded ClinReg Consulting Services to support medical device and pharmaceutical companies with strategic regulatory and clinical consulting focused on FDA approval and international product registrations. ClinReg has helped numerous companies navigate the path toward regulatory approval for pharmaceuticals and devices, including helping secure FDA approval for the first intraocular sustained-release drug delivery product.
“Dr. Gordon built a wonderful team of professionals at ClinReg with a proven track record of bringing innovative technology to market. Her contribution to drug, biologic, and medical device development has been to the great benefit of patients and healthcare providers worldwide,” colleague Lee Kramm, MD, MSE, said in a news release.
In cooperation with Dr. Gordon, three of ClinReg’s consultants, Dr. Kramm, Debe Deck, and Maureen Johnson, RN, are launching a new venture–Regulatory Pathways Group–which will offer the same services ClinReg provided, together with new methods, resources, and opportunities for medical device, pharmaceutical, and biologics companies.
“It has been the pleasure of a lifetime to build ClinReg, and in partnership with our clients, deliver meaningful impact and health outcomes for patients and providers,” Dr. Gordon said. “I’m thrilled to turn over the reins to Lee, Debe, Maureen. Working with our excellent bench of consultants, I couldn’t be more confident that they will continue to provide exceptional services and deliver impact.”
“During my time as a medical officer at FDA, ClinReg Consulting was recognized as among the most professional consulting groups. It has been very gratifying to be part of the ClinReg team for the past 9 years and I’m really looking forward to having Regulatory Pathways carry on Judy’s legacy and expanding on ClinReg’s superior reputation by providing an even greater range of consulting services,” said Dr. Kramm.
Regulatory Pathways is also partnering with ClinReg’s roster of consultants to provide a seamless transition of services for ClinReg clients. “Regulatory Pathways will expand ClinReg’s consultant roster, adding additional regulatory professionals in new areas. We are excited about this opportunity for growth and the ability to assist a wider variety of clients,” said Debe Deck, SVP of Program Management and Client Services at Regulatory Pathways.
“Judy has been a strategic and impactful leader, a generous mentor, and a caring friend to all of us. We cannot thank her enough for her decades of stewardship and commitment. She is a luminary in our industry and we at Regulatory Pathways take great pleasure in being able to continue her legacy,” said Maureen Johnson, SVP of Consulting Resources and Operations.